# Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

> **NCT03496649** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Bordeaux** · enrollment: 20 (estimated)

## Conditions studied

- Groin Injury
- Tendinopathy

## Interventions

- **DRUG:** Dysport 500 Unit Powder for Injection

## Key facts

- **NCT ID:** NCT03496649
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-02
- **Primary completion:** 2020-08-02
- **Final completion:** 2020-08-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03496649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03496649, "Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03496649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*